Sign in
Taking people in NetherlandsPhase 1

AZD4063 for adults with dilated cardiomyopathy caused by a PLN R14del gene change

Tests AZD4063 for safety in adults with PLN R14del dilated cardiomyopathy.

Key facts

Who runs it
AstraZeneca AB
Where
Amsterdam, Groningen, Rotterdam, and Utrecht, NetherlandsSee the 4 sites
Registry title
A trial to learn how safe AZD4063 is, how it moves throughout the body over time, and how it affects the levels of PLN mRNA in adults with dilated cardiomyopathy because of an R14del mutation in the PLN gene
Status
Recruiting
Phase
Phase 1
People taking part
23 people, planned
Started
20 Nov 2025
Expected to end
29 Oct 2027
Type of study
Interventional
Record updated
20 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with dilated cardiomyopathy caused by an R14del mutation in the PLN gene. Dilated cardiomyopathy is a weakened, enlarged heart muscle. The trial tests the safety of AZD4063 and how it moves through the body.

Age
18 Years and older
Sex
All sexes can join.
Disease stage
Dilated cardiomyopathy caused by the PLN R14del gene change.
Biomarker or test result
An R14del mutation in the PLN gene.

Main reasons for not taking part

  • Healthy volunteers cannot join.

Where in Netherlands

  • Amsterdam UMC StichtingAmsterdam, NetherlandsTaking people
  • Universitair Medisch Centrum GroningenGroningen, NetherlandsTaking people
  • Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Rotterdam, NetherlandsTaking people
  • Universitair Medisch Centrum UtrechtUtrecht, NetherlandsTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
AZD4063 for adults with dilated cardiomyopathy caused by a PLN R14del gene changeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
20 July 2026